The Department of Global Health promotes and supports the use of economic evaluation for priority setting at both global and national levels through the Disease Control Priorities Network (DCPN). DCPN promotes evidence-based priority setting to inform policy and improve resource allocations for health in low-and-middle-income-countries, through the publication of Disease Control Priorities, 3rd Edition, and direct engagement with policymakers, health professionals, academic organizations, and researchers. Led by Charles Mock, PhD, and Dean Jamison, PhD.
Health Economics Overview
Between 2011 and 2017, Disease Control Priorities Network in the Department of Global Health coordinated and managed the production of the 3rd edition of Disease Control Priorities (DCP3). Building on its predecessors, DCP1 (1993) and DCP2 (2006), this third edition provides an up-to-date, comprehensive review of the efficacy, effectiveness, and cost-effectiveness of priority health interventions for a variety of diseases and conditions . It goes beyond earlier editions by providing systematic economic evaluation of policy choices with the goal of influencing program design and supporting health priority setting at the global and country level. The project is led by Dean Jamison and Charles Mock.
The University of Washington is working with partners in Sub-Saharan Africa, Latin America, China and the Middle East to conduct economic evaluation of the prevention and treatment of the most pressing conditions and diseases contributing to the global burden of disease through training workshops and collaborative research. Together, these components will provide the most comprehensive and up-to-date economic information to guide regional and national level policy making, along with dispersed capacity for evidence-based priority-setting for health.
The Global Health Cost Consortium (GHCC), funded by the Bill & Melinda Gates Foundation, is a project that aims to improve the efficiency and effectiveness of the global response to the HIV and TB epidemics by improving the availability and access to high quality economic data on costs of HIV and TB interventions. The GHCC Consortium has produced The Reference Case for Estimating the Costs of Global Health Services and Interventions -- a guide to ensuring that the process of cost estimation is transparent and clear, with the goal of enhancing the interpretation and use of quality cost data for decision-making. The project is also generating improved cost estimates through the collection, extraction and analysis of published and primary data to: (1) update a web-based Unit Cost Study Repository (UCSR), initially established by Avenir Health; and (2) establish a new dynamic costing tool, called UCost.